“Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis”. 2025. Open Access Indonesian Journal of Medical Reviews 5 (6): 1772-89. https://doi.org/10.37275/oaijmr.v5i6.818.